Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

NSE : SUVENPHARBSE : 543064ISIN CODE : INE03QK01018Industry : Pharmaceuticals & DrugsHouse : Private

BSE1108.2552.7 (+4.99 %)

PREV CLOSE ( ) 1055.55

OPEN PRICE ( ) 1046.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 8737

TODAY'S LOW / HIGH ( )1046.00 1146.15

52 WK LOW / HIGH ( )586.1 1359

NSE1104.9050.15 (+4.75 %)

PREV CLOSE( ) 1054.75

OPEN PRICE ( ) 1056.95

BID PRICE (QTY) 1104.90 (23)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 154325

TODAY'S LOW / HIGH( ) 1053.65 1147.10

52 WK LOW / HIGH ( )585.2 1360

Chairman	Vivek Sharma
Managing Director	V Prasada Raju
Company Secretary	Kundan Kumar Jha
Non Executive Director	Pankaj Patwari Shweta Jalan
Independent Director	Jai Shankar Krishnan
Non Executive Independent Director	K G Ananthakrishnan Matangi Gowrishankar Vinod Rao UB Pravin Rao
Non Independent Director	Vinod Padikkal

Incorporation Year : 06-11 2018

Registered Office :

Address : 215 Atrium, C Wing, 8th Floor, 819-821,Andheri, Kurla Road, Chakala,Andheri (East), Chakala Midc Mumbai,
Maharashtra-400093 .

Phone : 022-61539999

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE